Errata: "Group VIA phospholipase A2in both host and tumor cells is involved in ovarian cancer development" (FASEB Journal (2010) 24, (4103-4116) doi:10.1096/fj.10-161356);Group VIA phospholipase A2 in both host and tumor cells is involved in ovarian cancer development

FASEB Journal

Volumn 24, Issue 10, 2010, Pages 4103-4116

  Li, Hui ^a   Zhao, Zhenwen ^a   Wei, Gang ^a   Yan, Libo ^a   Wang, Dongmei ^a   Zhang, Hong ^a,b   Sandusky, George Earl ^a,b   Turk, John ^c   Xu, Yan ^a  

^a INDIANA UNIVERSITY   (United States)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lysophosphatidic acid; Tumor microenvironment

Indexed keywords

LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2 GROUP VI; PHOSPHOLIPASE A2 GROUP VIA; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; PHOSPHOLIPASE A2 GROUP X; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL INTERACTION; CELL INVASION; CELL MIGRATION; HOST CELL; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; TUMOR CELL; ANIMAL; CELL LINE; CHEMISTRY; ENZYMOLOGY; FEMALE; KNOCKOUT MOUSE; METABOLISM; METASTASIS; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING;

MUS;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; FEMALE; GROUP X PHOSPHOLIPASES A2; MICE; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 77957850780     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-161356ERR     Document Type: Erratum

References (52)

1. Sengupta, S., Wang, Z., Tipps, R., and Xu, Y. (2004) Biology of LPA in health and disease. Semin. Cell Dev. Biol. 15, 503-512
2. Xu, Y., Sengupta, S., Singh, S., and Steinmetz, R. (2006) Novel lipid signaling pathways in ovarian cancer cells. Cell Sci. Rev. 3, 168-197
3. Mills, G. B., and Moolenaar, W. H. (2003) The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 3, 582-591
4. Murph, M. M., Liu, W., Yu, S., Lu, Y., Hall, H., Hennessy, B. T., Lahad, J., Schaner, M., Helland, A., Kristensen, G., Borresen- Dale, A. L., and Mills, G. B. (2009) Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis. PLoS ONE 4, e5583
5. Aoki, J., Inoue, A., and Okudaira, S. (2008) Two pathways for lysophosphatidic acid production. Biochim. Biophys. Acta 1781, 513-518
6. Balsinde, J., Balboa, M. A., Insel, P. A., and Dennis, E. A. (1999) Regulation and inhibition of phospholipase A2. Annu. Rev. Pharmacol. Toxicol. 39, 175-189
7. Kudo, I., and Murakami, M. (1999) [Phospholipase A2]. Tanpakushitsu Kakusan Koso 44, 1013-1024
8. Kudo, I., and Murakami, M. (2002) Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. 68-69, 3-58
9. Ramanadham, S., Yarasheski, K. E., Silva, M. J., Wohltmann, M., Novack, D. V., Christiansen, B., Tu, X., Zhang, S., Lei, X., and Turk, J. (2008) Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null mice. Am. J. Pathol. 172, 868-881
10. Zhao, X., Wang, D., Zhao, Z., Xiao, Y., Sengupta, S., Xiao, Y., Zhang, R., Lauber, K., Wesselborg, S., Feng, L., Rose, T. M., Shen, Y., Zhang, J., Prestwich, G., and Xu, Y. (2006) Caspase-3-dependent activation of calcium-independent phospholipase A2 enhances cell migration in non-apoptotic ovarian cancer cells. J. Biol. Chem. 281, 29357-29368
11. Song, Y., Wilkins, P., Hu, W., Murthy, K. S., Chen, J., Lee, Z., Oyesanya, R., Wu, J., Barbour, S. E., and Fang, X. (2007) Inhibition of calcium-independent phospholipase A2 suppresses proliferation and tumorigenicity of ovarian carcinoma cells. Biochem. J. 406, 427-436 (Pubitemid 47425449)
12. Bissell, M. J., Weaver, V. M., Lelievre, S. A., Wang, F., Petersen, O. W., and Schmeichel, K. L. (1999) Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Res. 59, 1757-1763s; discussion 1763s-1764s
13. Bao, S., Miller, D. J., Ma, Z., Wohltmann, M., Eng, G., Ramanadham, S., Moley, K., and Turk, J. (2004) Male mice that do not express group VIA phospholipase A2 produce spermatozoa with impaired motility and have greatly reduced fertility. J. Biol. Chem. 279, 38194-38200
14. Bao, S., Song, H., Wohltmann, M., Ramanadham, S., Jin, W., Bohrer, A., and Turk, J. (2006) Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis. J. Biol. Chem. 281, 20958-20973
15. Bao, S., Bohrer, A., Ramanadham, S., Jin, W., Zhang, S., and Turk, J. (2006) Effects of stable suppression of group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells. J. Biol. Chem. 281, 187-198
16. Ren, J., Xiao, Y. J., Singh, L. S., Zhao, X., Zhao, Z., Feng, L., Rose, T. M., Prestwich, G. D., and Xu, Y. (2006) Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res. 66, 3006-3014
17. Shen, Z., Belinson, J., Morton, R. E., Xu, Y., and Xu, Y. (1998) Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells. Gynecol. Oncol. 71, 364-368
18. Eder, A. M., Sasagawa, T., Mao, M., Aoki, J., and Mills, G. B. (2000) Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2. Clin. Cancer Res. 6, 2482-2491
19. Fang, X., Yu, S., Bast, R. C., Liu, S., Xu, H. J., Hu, S. X., LaPushin, R., Claret, F. X., Aggarwal, B. B., Lu, Y., and Mills, G. B. (2004) Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells. J. Biol. Chem. 279, 9653-9661
20. Chou, C. H., Wei, L. H., Kuo, M. L., Huang, Y. J., Lai, K. P., Chen, C. A., and Hsieh, C. Y. (2005) Up-regulation of interleukin- 6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor. Carcinogenesis 26, 45-52
21. Moran, J. M., Buller, R. M., McHowat, J., Turk, J., Wohltmann, M., Gross, R. W., and Corbett, J. A. (2005) Genetic and pharmacologic evidence that calcium-independent phospholipase A2beta regulates virus-induced inducible nitric-oxide synthase expression by macrophages. J. Biol. Chem. 280, 28162-28168
22. Li, H., Wang, D., Zhang, H., Kirmani, K., Zhao, Z., Steinmetz, R., and Xu, Y. (2009) Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/ metastasis of mouse ovarian cancer in immunocompetent mice. Mol. Cancer Ther. 8, 1692-1701
23. Bao, S., Jin, C., Zhang, S., Turk, J., Ma, Z., and Ramanadham, S. (2004) Beta-Cell Calcium-independent group VIA phospholipase A(2) (iPLA(2)beta): tracking iPLA(2)beta movements in response to stimulation with insulin secretagogues in INS-1 cells. Diabetes 53(Suppl. 1), S186-S189
24. Kim, K. S., Sengupta, S., Berk, M., Kwak, Y. G., Escobar, P. F., Belinson, J., Mok, S. C., and Xu, Y. (2006) Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo. Cancer Res. 66, 7983-7990 (Pubitemid 44299162)
25. Sengupta, S., Kim, K. S., Berk, M. P., Oates, R., Escobar, P., Belinson, J., Li, W., Lindner, D. J., Williams, B., and Xu, Y. (2007) Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion. Oncogene 26, 2894-2901 (Pubitemid 46701441)
26. Zhao, Z., and Xu, Y. (2010) An extremely simple method for extraction of lysophospholipids and phospholipids from blood samples. J. Lipid Res. 51, 652-659
27. Zhao, Z., and Xu, Y. (2009) Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires pre-separation of lysophosphatidylcholine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877, 3739-3742
28. Sengupta, S., Xiao, Y. J., and Xu, Y. (2003) A novel laminin-induced LPA autocrine loop in the migration of ovarian cancer cells. FASEB J. 17, 1570-1572
29. Hazen, S. L., Zupan, L. A., Weiss, R. H., Getman, D. P., and Gross, R. W. (1991) Suicide inhibition of canine myocardial cytosolic calcium-independent phospholipase A2. Mechanism-based discrimination between calcium-dependent and -independent phospholipases A2. J. Biol. Chem. 266, 7227-7232
30. Balsinde, J., and Dennis, E. A. (1996) Bromoenol lactone inhibits magnesium-dependent phosphatidate phosphohydrolase and blocks triacylglycerol biosynthesis in mouse P388D1 macrophages. J. Biol. Chem. 271, 31937-31941
31. Xu, Y., Xiao, Y. J., Zhu, K., Baudhuin, L. M., Lu, J., Hong, G., Kim, K. S., Cristina, K. L., Song, L., F, S. W., Elson, P., Markman, M., and Belinson, J. (2003) Unfolding the pathophysiological role of bioactive lysophospholipids. Curr. Drug Targets Immune Endocr. Metabol. Disord. 3, 23-32
32. Bast, R. C., Jr., Hennessy, B., and Mills, G. B. (2009) The biology of ovarian cancer: new opportunities for translation. Nat. Rev. Cancer 9, 415-428
33. Teo, S. T., Yung, Y. C., Herr, D. R., and Chun, J. (2009) Lysophosphatidic acid in vascular development and disease. IUBMB Life 61, 791-799
34. Kobayashi, N., Yamaguchi, A., and Nishi, T. (2009) Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes. J. Biol. Chem. 284, 21192-21200
35. Takabe, K., Kim, R. H., Allegood, J. C., Mitra, P., Ramachandran, S., Nagahashi, M., Harikumar, K. B., Hait, N. C., Milstien, S., and Spiegel, S. Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J. Biol. Chem. 285, 10477-10486
36. Tokumura, A., Majima, E., Kariya, Y., Tominaga, K., Kogure, K., Yasuda, K., and Fukuzawa, K. (2002) Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 277, 39436-39442
37. Umezu-Goto, M., Kishi, Y., Taira, A., Hama, K., Dohmae, N., Takio, K., Yamori, T., Mills, G. B., Inoue, K., Aoki, J., and Arai, H. (2002) Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 158, 227-233
38. Eichholtz, T., Jalink, K., Fahrenfort, I., and Moolenaar, W. H. (1993) The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291, 677-680
39. Holmes, C. E., Levis, J. E., and Ornstein, D. L. (2009) Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis. Clin. Exp. Metastasis 26, 653-661
40. Gupta, G. P., and Massague, J. (2004) Platelets and metastasis revisited: a novel fatty link. J. Clin. Invest. 114, 1691-1693
41. Boucharaba, A., Serre, C. M., Gres, S., Saulnier-Blache, J. S., Bordet, J. C., Guglielmi, J., Clezardin, P., and Peyruchaud, O. (2004) Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J. Clin. Invest. 114, 1714-1725
42. Xu, Y., Gaudette, D. C., Boynton, J. D., Frankel, A., Fang, X. J., Sharma, A., Hurteau, J., Casey, G., Goodbody, A., Mellors, A., Hobub, B. J., and Mills, G. B. (1995) Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin. Cancer Res. 1, 1223-1232
43. Xiao, Y., Chen, Y., Kennedy, A. W., Belinson, J., and Xu, Y. (2000) Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses. Ann. N. Y. Acad. Sci. 905, 242-259
44. Xiao, Y. J., Schwartz, B., Washington, M., Kennedy, A., Webster, K., Belinson, J., and Xu, Y. (2001) Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids. Anal. Biochem. 290, 302-313
45. Lee, Z., Swaby, R. F., Liang, Y., Yu, S., Liu, S., Lu, K. H., Bast, R. C., Jr., Mills, G. B., and Fang, X. (2006) Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer. Cancer Res. 66, 2740-2748
46. van Corven, E. J., Groenink, A., Jalink, K., Eichholtz, T., and Moolenaar, W. H. (1989) Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell 59, 45-54
47. Wang, D., Zhao, Z., Caperell-Grant, A., Yang, G., Mok, S. C., Liu, J., Bigsby, R. M., and Xu, Y. (2008) S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells. Mol. Cancer Ther. 7, 1993-2002
48. Schmid, G., Guba, M., Ischenko, I., Papyan, A., Joka, M., Schrepfer, S., Bruns, C. J., Jauch, K. W., Heeschen, C., and Graeb, C. (2007) The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1. J. Cell. Biochem. 101, 259-270
49. Vargaftig, B. B., and Zirinis, P. (1973) Platelet aggregation induced by arachidonic acid is accompanied by release of potential inflammatory mediators distinct from PGE2 and PGF2. Nat. New Biol. 244, 114-116
50. Hyde, C. A., and Missailidis, S. (2009) Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. Int. Immunopharmacol. 9, 701-715
51. Gil, O. D., Lee, C., Ariztia, E. V., Wang, F. Q., Smith, P. J., Hope, J. M., and Fishman, D. A. (2008) Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner. Gynecol. Oncol. 108, 361-369
52. Merritt, W. M., Lin, Y. G., Spannuth, W. A., Fletcher, M. S., Kamat, A. A., Han, L. Y., Landen, C. N., Jennings, N., De Geest, K., Langley, R. R., Villares, G., Sanguino, A., Lutgendorf, S. K., Lopez-Berestein, G., Bar-Eli, M. M., and Sood, A. K. (2008) Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. J. Natl. Cancer Inst. 100, 359-372